Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Outset Medical, Inc.

$4.32 -5.68% NASDAQ: OM · 15-min delayed
  • SAN JOSE, California
  • Public · NASDAQ: OM
  • 310 employees
$84.9MMarket cap
$119.5MRevenue · FY2025
-$81.7MNet income
310Employees
OMNASDAQ
2020IPO

About Outset Medical, Inc.

Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$119.5M
Net income
-$81.7M
Total assets
$264.5M
Market cap
$84.9M
Gross margin
39.1%
Operating margin
-55.8%
Net margin
-68.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$119.5M
Cost of revenue
$72.7M
Gross profit
$46.8M
Operating expenses
$113.5M
Operating income
-$66.7M
Income tax
$718.0K
Net income
-$81.7M
EPS (basic)
$-5.37
EPS (diluted)
$-5.37

Balance sheet

Total assets
$264.5M
Current assets
$250.9M
Total liabilities
$137.5M
Current liabilities
$37.6M
Shareholders’ equity
$127.0M

Cash flow

Operating cash flow
-$46.3M
Investing cash flow
-$97.7M
Financing cash flow
$55.5M
Net cash flow
-$88.5M

Statements via Polygon.io (SEC filings)

NASDAQ: OM
$4.32 -5.68%

15-minute delayed · data by Polygon.io

Past year

$3.16 $21.24

52-week range

Market cap
$84.9M
EPS (diluted)
$-5.37
Shares outstanding
19.7M
Open
Day range
Prev close
Volume
IPO date
Sep 15, 2020

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Reported a net loss of $81.7M in FY2025.
  • Revenue grew 16% from FY2021 to FY2025.
  • Gross margin of 39.1%, net margin -68.3%.
  • Trading 80% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Outset Medical, Inc..

Write a review
Newsroom

News about Outset Medical, Inc.

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →